GLPwatch

Adlyxin vs Mounjaro

Drug comparison

Last updated 2026-05-28 15:46 UTC

Adlyxin (lixisenatide) and Mounjaro (tirzepatide) are both injectable medications for type 2 diabetes, but they contain different active ingredients and are made by different companies. Adlyxin is made by Sanofi and contains lixisenatide, while Mounjaro is made by Eli Lilly and contains tirzepatide. Both are given as shots under the skin, but they work in slightly different ways to help control blood sugar.

AI summary of the sources below.

Adlyxin Mounjaro
Active ingredientlixisenatidetirzepatide
Manufacturersanofieli-lilly
Routesubcutaneous injectionsubcutaneous injection
FDA-approved fortype 2 diabetestype 2 diabetes
Label updated2026-04-22

Compare full details on the Adlyxin and Mounjaro pages.